Expanding access to robotic surgery with a patient-first vision

By Prof. Matin Sheriff MBBS (Lon), Ph.D. (Hon), FRCS, FRCS (Urol), FEBU
Consultant Urological Surgeon; Director of Robotic Surgery & West Kent Urology Cancer Centre, Medway NHS Foundation Trust, Kent, UK
Executive Chairman, MAC (Medics Across Continents)

Indications, Safety, and WarningsIndicationsThe Hugo™ Robotically Assisted Surgery (RAS) System is intended to assist in the accurate control of instruments and accessories including rigid endoscopes, blunt and sharp endoscopic dissectors, scissors, forceps/graspers, needle holders, electrosurgical tools and accessories for endoscopic manipulation of tissue, including grasping, cutting, blunt and sharp dissection, approximation, ligation, electrosurgery, and suturing during minimally invasive urologic surgical procedures. The system is indicated for adult use. It is intended to be used by trained physicians in an operating room environment in accordance with the representative surgical procedures set forth in the Hugo™ RAS System Indications Document.Potential Adverse EventsThe potential adverse events associated with the use of robotically assisted surgical devices include, but are not limited to: arrhythmia, bleeding, blunt trauma, bowel perforation, burns (varying degrees, bowel, thermal), crushing injury, delay of treatment (prolonged procedure), electric shock, foreign body in patient, infection, inflammation, tissue damage/trauma, toxicity, or vessel perforation.ContraindicationsThere are no device specific contraindications for the Hugo™ RAS system.The demonstration of safety and effectiveness for the specific procedures discussed in the labeling was based on evaluation of the device as a surgical tool that assists in the accurate control of robotically-controlled instruments to perform coordinated surgical tasks. The evaluation did not include assessment of outcomes related to the treatment of cancer (e.g., overall survival, disease-free survival, local recurrence) or any specific treatment of any underlying disease or condition.Refer to Hugo™ RAS System user’s guide, indications document and other supplemental labeling for detailed information regarding the procedures, indications, contraindications, warnings, precautions, and potential complications/adverse events. Contact Medtronic at rs.globalroboticsservicesupport@medtronic.com to request the latest version or visit Medtronic.com/manuals.

Nine years ago, when we launched our robotic program at Medway Maritime Hospital, our vision was simple, but ambitious: Put patients first by offering the highest quality and most innovative care possible. We wanted to ensure that every patient received treatment.

That vision hasn’t changed. What has changed is the scale. Today, as we expand our program by adding a second robotic platform — the Hugo™ robotic-assisted surgery (RAS) system — we are creating opportunities for more patients to experience the benefits of minimally invasive robotic procedures.

“We are creating opportunities for more patients to experience the benefits of minimally invasive robotic procedures.”

Prof. Matin Sheriff MBBS (Lon), Ph.D. (Hon), FRCS, FRCS (Urol), FEBU
Consultant Urological Surgeon; Director of Robotic Surgery & West Kent Urology Cancer Centre, Medway NHS Foundation Trust, Kent, UK;
Executive Chairman, MAC (Medics Across Continents)

Building for the future with a robotic surgery training center

To impact more patients, we’re not just performing robotic surgery—we’re training those who will shape its future. That’s why we are working to establish a robotic training center at our university. This will allow us to train the next generation of surgeons, nurses, technicians, and OR staff, not just locally or nationally, but in partnership with international colleagues. For me, that’s the true meaning of having a big vision — putting patients first while making sure the healthcare providers of tomorrow are prepared to do the same.

Expanding our hospital’s capacity

Working within the National Health Service, we face challenges familiar to many healthcare providers: balancing quality with cost and managing limited capacity. Right now, we have two dedicated robotic theatres — one fully dedicated to the Hugo™ RAS system — and we hope to expand further. Our biggest challenge is building capacity. As we expand, we need to acquire space for additional operating theatres and build a larger pool of trained surgeons, nurses, and technical staff. Introducing the Hugo™ RAS system has already given us an edge in recruitment and retention. The excitement it has created is drawing in top talent and giving our teams fresh momentum.

Why we chose the Hugo™ RAS system

When we decided to add a second robotic platform for our hospital, it was not a choice we took lightly. We went through a rigorous procurement process, carefully evaluating every system currently available in the UK. What ultimately convinced us was a combination of unique advantages that align with our priorities.

The first is the imaging quality. The Karl Storz IMAGE1 S™* RUBINA™* vision system on the Hugo™ RAS system is exceptional — crisp, clear, and unlike anything else we have trialed. For surgeons, vision is everything, and this system provides a level of detail that directly enables precision in the operating room.¹

Second, the modular architecture of the Hugo™ RAS system makes a real difference. Unlike integrated systems, where all arms extend from a central pillar, this design allows each arm to be positioned independently. That provides flexibility, true multi-quadrant access, and stability during procedures. For complex surgeries, the ability to approach from multiple angles without re-docking helps streamline workflows.

The Hugo™ RAS system open console is another key difference. The console allows surgeons to fully engage with the theatre team. This open design fosters better communication and provides an exceptional training environment. Multiple trainees can observe in 3D, share the surgeon’s view, and engage in the case in real time.

Finally, the Touch Surgery™ ecosystem sets the Hugo™ RAS system apart. This technology enables case recording of procedures, live streaming, and post-procedure performance insights that transform how we teach, train, and continuously improve.²

The partnership with Medtronic matters

For us, a vendor relationship doesn’t end with the purchase of a product. It’s really just the beginning. What convinced me further was Medtronic’s commitment to long-term partnership — ongoing training, support, and a shared focus on patients. That alignment of vision is critical for sustainable success.

Looking ahead to the future of robotics

The buzz around our program today reminds me of the excitement we felt when we first introduced robotics nearly a decade ago — only now, the energy has reached a new level. I strongly believe that expanding with the Hugo™ RAS system was the right choice, and I am confident that time will prove that decision correct.

Stay updated on the Hugo™ RAS system.

RAS training and program development.

Keep me updated